Now in its third year, the trial is led by The Wistar Institute in collaboration with INOVIO, AstraZeneca, and clinical investigators at the University of Pennsylvania. It is funded by the Coronavirus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback